Clinical Trial Update: Efficacy and Safety Study of SUNPG1622 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SUNPG1622 in active ankylosing spondylitis or non-radiographic axial spondyloarthritis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Non-radiographic Axial Spondyloarthritis

Drugs mentioned

• SUNPG1622

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21